Highlights form the Tenth Annual Scientific Meeting of the American
Society of Hypertension will be made available FREE via the ASH-EHLB mail list.
To subscribe and receive information about this meeting, highlights
delivered to your email address during the meeting and a chance to
communicate with presenters, send a subscribe message (SUBSCRIBE

SUBSCRIBE John Doe

Meanwhile, here is the schedule pf sessions for:

SATURDAY, MAY 20
================

10:00 AM to 12:00 PM
--------------------
Theme I: Heart and {*filter*} Vessels
      Cloning Angiotensin II Responsive Genes in Vascular
      Smooth Muscle
         Mark Taubman, MD, New York, NY
      Original Communications
Theme II: Clinical Pharmacology of Antihypertensive {*filter*}
      Circadian Regulation of {*filter*} Pressure: Mechanisms and
      Therapeutic Implications
         Bjorn Lemmer, MD, Frankfurt, Germany
      Original Communications
Theme III: Clinical Hypertension
      Transition from Clinical Trials to Clinical Practice
         Peter Sleight, MD, Oxford, England
      Original Communications

1:00 PM to 3:00 PM
------------------
Theme I: RENAL MECHANISMS IN HYPERTENSION
      Chronic Renal Failure
         Howard Jacob, PhD, Charlestown, MA
      Renal Medullary Mechanisms in Hypertension
         Richard J. Roman, PhD, Milwaukee, WI
      Nitric Oxide Mediation of Pressure Natriuresis
         L. Gabriel Navar, PhD, New Orleans, LA
      Dopamine Signaling Defects in SHR
         Pedro A. Jose, MD, PhD, Washington, DC
      Autocrine Inhibition of Renal Epithelial Na+/K+ ATPase by
      Nitric Oxide
         Nicolas J. Guzman, MD, Gainesville, FL
      Discussion
Theme II: HOW LOW SHOULD {*filter*} PRESSURE BE?
      Epidemiology
         Astrid Fletcher, PhD, London, England
      Kidney
         Paul K. Whelton, MD, MSc, Baltimore, MD
      Heart and Vessels
         Diederick E. Grobbee, MD, PhD, Rotterdam, The Netherlands
      Treatment and Myocardial Ischemia
         John M. Cruickshank, MD, Cheshire, England
      Discussion

1:00 PM to 4:30 PM
Theme III: CLINICAL TRIALS NEW FINDINGS FROM COMPLETED STUDIES
      AND FUTURE DIRECTIONS
      TOHMS
         Richard H. Grimm, Jr, MD, PhD, Minneapolis, MN
      Update on the VA Cooperative Study Group on Antihypertensive
      Agents: Monotherapy of Hypertension Trial
         Barry J. Materson, MD, MBA, Miami, FL
      SHEP
         Jeffrey L. Probstfield, MD, Seattle, WA
      New Trials on Antihypertensive {*filter*} Outside the United
      States
         Lennart Hansson, MD, Uppsala, Sweden
      Panel Discussion
      ALLHAT
         Jackson T. Wright, Jr, MD, PhD, Cleveland, OH
      Prevention and Treatment of Hypertension Study (PATHS):
      {*filter*} Reduction for Hypertension and Upper Normal {*filter*}
      Pressure
         William C. Cushman, MD, Memphis, TN
      Clinical Trials with Ambulatory {*filter*} Pressure Monitoring:
      Evidence from the Syst-Eur Trial
         Jan A. Staessen, MD, PhD, Leuven, Belgium
      Panel Discussion

3:00 PM to 5:00 PM
------------------
Theme I: ANGIOTENSIN-DEPENDENT MECHANISMS IN HYPERTENSION
      Ren 2 Transgenic Rat Model of Hypertension
         To Be Announced
      Renal Mechanisms of Hypertension in the Ren 2 Transgenic Rat
         Kenneth D. Mitchell, PhD, New Orleans, LA
      Angiotensin (1-7): A Novel Hormone of the RAS
         Carlos Ferrario, MD, Winston-Salem, NC
      Chymase-Dependent Angiotension II Forming System in Humans
         Hidenori Urata, MD, Berlin, Germany
      Mechanisms of Angiotensin II Mediated Intracellular
      Signaling
         Kenneth E. Bernstein, MD, Atlanta, GA
      Discussion
Theme II: NEW INSIGHTS INTO RENOVASCULAR HYPERTENSION
      Which Diagnostic Tests Are Best For Ischemic Nephropathy?
         Samuel J. Mann, MD, New York, NY
      The Role of Surgery in the Treatment of Ischemic Nephropathy
         Richard H. Dean, MD, Winston-Salem, NC
      The Role of Angioplasty and Stents in the Treatment of
      Ischemic Nephropathy
         Thomas Sos, MD, New York, NY
      Ischemic Nephropathy:  The Medical Viewpoint
         Marc A. Pohl, MD, Cleveland, OH
      Discussion

--
John Mack
----------------------------------------------
John Mack       1-215-949-0490
Pharmaceutical Information Associates, Ltd.
2761 Trenton Road, Levittown, PA 19056 USA
Creators of PharmInfoNet, a Web site devoted to pharmaceutical information.
URL: http://www.***.com/




-----------------------------------------------